Meningeal blood flow is controlled by H2S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway

British Journal of Pharmacology

Volumn 173, Issue 3, 2016, Pages 431-445

  Dux, Mária ^a   Will, Christine ^b   Vogler, Birgit ^b   Filipovic, Milos R ^b   Messlinger, Karl ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HYDROGEN SULFIDE; NITRIC OXIDE; NITROXYL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; NITROGEN OXIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPA1 PROTEIN, RAT;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DURA MATER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; HISTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LIMIT OF DETECTION; MALE; MENINGEAL BLOOD FLOW; MENINX; MORPHOLOGY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; VASODILATATION; ANIMAL; BRAIN CIRCULATION; METABOLISM; VASCULARIZATION; WISTAR RAT;

ANIMALS; CEREBROVASCULAR CIRCULATION; HYDROGEN SULFIDE; MALE; MENINGES; NITROGEN OXIDES; RATS, WISTAR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 84956678586     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13164     Document Type: Article

References (92)

1. Akerman S, Williamson DJ, Kaube H, Goadsby PJ, (2002). Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 137: 62-68.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
5. Asimakopoulou A, Panopoulos P, Chasapis CT, Coletta C, Zhou Z, Cirino G, et al. (2013). Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). Br J Pharmacol 169: 922-932.
6. Bellamy J, Bowen EJ, Russo AF, Durham PL, (2006). Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23: 2057-2066.
7. Bhatt DK, Ramachandran R, Christensen SL, Gupta S, Jansen-Olesen I, Olesen J, (2015). CGRP infusion in unanesthetized rats increases expression of c-Fos in the nucleus tractus solitarius and caudal ventrolateral medulla, but not in the trigeminal nucleus caudalis. Cephalalgia 35: 220-233.
8. Bigal ME, Walter S, Rapoport AM, (2013). Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache 53: 1230-1244.
9. Bigal ME, Walter S, Rapoport AM, (2015). Therapeutic antibodies against CGRP or its receptor. Br J Clin Pharmacol doi: 10.1111/bcp.12591; Epub ahead of print.
10. Brain SD, Grant AD, (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84: 903-934.
11. Brian JE, Faraci FM, Heistad DD, (1996). Recent insights into the regulation of cerebral circulation. Clin Exp Pharmacol Physiol 23: 449-457.
12. Chertok VM, Kotsyuba AE, (2012). Distribution of H2S synthesis enzymes in the walls of cerebral arteries in rats. Bull Exp Biol Med 154: 104-107.
13. Chin KY, Qin C, Cao N, Kemp-Harper BK, Woodman OL, Ritchie RH, (2014). The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Br J Pharmacol 171: 1722-1734.
14. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Mõdis K, Panopoulos P, et al. (2012). Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci U S A 109: 9161-9166.
15. Covasala O, Stirn SL, Albrecht S, De Col R, Messlinger K, (2012). Calcitonin gene-related peptide receptors in rat trigeminal ganglion do not control spinal trigeminal activity. J Neurophysiol 108: 431-440.
16. Dux M, Schwenger N, Messlinger K, (2002). Possible role of histamine (H1- and H2-) receptors in the regulation of meningeal blood flow. Br J Pharmacol 137: 874-880.
17. Dux M, Sántha P, Jancsõ G, (2003). Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol 552: 859-867.
18. Eberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, et al. (2014). H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. Nat Commun 5: 4381-4397.
19. Ebersberger A, Averbeck B, Messlinger K, Reeh PW, (1999). Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89: 901-907.
20. Edelmayer RM, Le LN, Yan J, Wei X, Nassini R, Materazzi S, et al. (2012). Activation of TRPA1 on dural afferents: a potential mechanism of headache pain. Pain 153: 1949-1958.
21. Edvinsson L, (2001). Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. CNS Drugs 15: 745-753.
22. Edvinsson L, Goadsby PJ, (1995). Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 15: 272-276.
23. Edvinsson L, Uddman R, (1981). Adrenergic, cholinergic and peptidergic nerve fibres in dura mater-involvement in headache? Cephalalgia 1: 175-179.
24. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R, (1987). Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 7: 720-728.
25. Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L, (2010). Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169: 683-696.
26. Ellis A, Li CG, Rand MJ, (2000). Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol 129: 315-322.
27. Elvidge S, (2014). Anti-CGRP antibodies for migraine turn industry heads. Nat Biotechnol 32: 707.
28. Faraci FM, Heistad DD, (1991). Regulation of cerebral blood vessels by humoral and endothelium-dependent mechanisms. Update on humoral regulation of vascular tone. Hypertension 17: 917-922.
29. Feistel S, Albrecht S, Messlinger K, (2013). The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion. J Headache Pain 14: 93-101.
30. Filipovic MR, Miljkovic JL, Nauser T, Royzen M, Klos K, Shubina T, et al. (2012). Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols. J Am Chem Soc 134: 12016-12027.
31. Filipovic MR, Eberhardt M, Prokopovic V, Mijuskovic A, Orescanin-Dusic Z, Reeh P, et al. (2013). Beyond H2S and NO interplay: hydrogen sulfide and nitroprusside react directly to give nitroxyl (HNO). A new pharmacological source of HNO. J Med Chem 56: 1499-1508.
32. Flores-Santana W, Salmon DJ, Donzelli S, Switzer CH, Basudhar D, Ridnour L, et al. (2011). The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems. Antioxid Redox Signal 14: 1659-1674.
33. Fukuto JM, Carrington SJ, (2011). HNO signalling mechanisms. Antioxid Redox Signal 14: 1649-1657.
34. Fukuto JM, Switzer CH, Miranda KM, Wink DA, (2005). Nitroxyl (HNO): chemistry, biochemistry, and pharmacology. Annu Rev Pharmacol Toxicol 45: 335-355.
35. Geppetti P, Rossi E, Chiarugi A, Benemei S, (2012). Antidromic vasodilatation and the migraine mechanism. J Headache Pain 13: 103-111.
36. Gray DW, Marshall I, (1992). Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107: 691-696.
37. Gupta S, Mehrotra S, Avezaat CJJ, Villalõn CM, Saxena PR, Maassenvandenbrink A, (2006). Characterisation of CGRP receptors in the human isolated middle meningeal artery. Life Sci 79: 265-271.
38. Hoffmann J, Goadsby PJ, (2012). New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 14: 50-59.
39. Hope BT, Michael GJ, Knigge KM, Vincent SR, (1991). Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A 88: 2811-2814.
40. Huang D, Li S, Dhaka A, Story GM, Cao Y-Q, (2012). Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain 8: 66.
41. Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parsons A, (2001). Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 21: 643-655.
42. Kabil O, Banerjee R, (2014). Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal 20: 770-782.
43. Kabil O, Motl N, Banerjee R, (2014). H2S and its role in redox signaling. Biochim Biophys Acta 1844: 1355-1366.
44. Keller JT, Marfurt CF, (1991). Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 309: 515-534.
45. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
46. Kimura H, (2002). Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13-19.
47. Koulchitsky S, Fischer MJ, Messlinger K, (2009). Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia 29: 408-417.
48. Kunkler PE, Ballard CJ, Oxford GS, Hurley JH, (2011). TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation. Pain 152: 38-44.
49. Kurosawa M, Messlinger K, Pawlak M, Schmidt RF, (1995). Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114: 1397-1402.
50. Lambert GA, Donaldson C, Boers PM, Zagami AS, (2000). Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res 887: 203-210.
51. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J, (2002). CGRP may play a causative role in migraine. Cephalalgia 22: 54-61.
52. Lennerz JK, Rühle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, et al. (2005). Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507: 1277-1299.
53. Levy D, Burstein R, Strassman AM, (2005). Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58: 698-705.
54. Li J, Vause CV, Durham PL, (2008). Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196: 22-32.
55. May A, Goadsby PJ, (1999). The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19: 115-127.
56. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
57. Messlinger K, Hanesch U, Baumgärtel M, Trost B, Schmidt RF, (1993). Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol (Berl) 188: 219-237.
58. Messlinger K, Suzuki A, Pawlak M, Zehnter A, Schmidt RF, (2000). Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat. Br J Pharmacol 129: 1397-1404.
59. Messlinger K, Fischer MJM, Lennerz JK, (2011). Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60: 82-89.
60. 2S. Angew Chem Int Ed Engl 52: 12061-12064.
61. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, et al. (2003). A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci U S A 100: 9196-9201.
62. Moschiano F, D'Amico D, Usai S, Grazzi L, Di Stefano M, Ciusani E, et al. (2008). Homocysteine plasma levels in patients with migraine with aura. Neurol Sci 29 (Suppl. 1): S173-S175.
63. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD, (1989). Pain mechanisms underlying vascular headaches. Progress report 1989. Rev Neurol (Paris) 145: 181-193.
64. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, et al. (2011). Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: 1259-1268.
65. Nozaki K, Moskowitz MA, Maynard KI, Koketsu N, Dawson TM, Bredt DS, et al. (1993). Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab 13: 70-79.
66. Olesen J, (2008). The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120: 157-171.
67. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P, (2009). Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8: 679-690.
68. Owman C, (1990). Peptidergic vasodilator nerves in the peripheral circulation and in the vascular beds of the heart and brain. Blood Vessels 27: 73-93.
69. Panconesi A, Bartolozzi ML, Guidi L, (2009). Migraine pain: reflections against vasodilatation. J Headache Pain 10: 317-325.
70. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, et al. (2001). Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A 98: 10463-10468.
71. Paolocci N, Katori T, Champion HC, St John ME, Miranda KM, Fukuto JM, et al. (2003). Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci U S A 100: 5537-5542.
72. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
73. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J, (2005). BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77: 202-213.
74. Petersen KA, Birk S, Kitamura K, Olesen J, (2009). Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders. Cephalalgia 29: 23-30.
75. Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD, (2010). Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res 87: 760-768.
76. Pozsgai G, Hajna Z, Bagoly T, Boros M, Kemény Á, Materazzi S, et al. (2012). The role of transient receptor potential ankyrin 1 (TRPA1) receptor activation in hydrogen-sulphide-induced CGRP-release and vasodilation. Eur J Pharmacol 689: 56-64.
77. Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M, (2008). Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28: 226-236.
78. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, et al. (2001). Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124: 2490-2502.
79. Rosenthal J, Lippard SJ, (2010). Direct detection of nitroxyl in aqueous solution using a tripodal copper(II) BODIPY complex. J Am Chem Soc 132: 5536-5537.
80. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V, (2000). Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20: 907-918.
81. Schlechtweg PM, Röder J, Fischer MJ, Neuhuber W, Messlinger K, (2009). Increase in NADPH-diaphorase-positive and neuronal NO synthase immunoreactive neurons in the rat spinal trigeminal nucleus following infusion of a NO donor-evidence for a feed-forward process in NO production involved in trigeminal nociception. Cephalalgia 29: 566-579.
82. Storer RJ, Akerman S, Goadsby PJ, (2004). Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142: 1171-1181.
83. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
84. Strecker T, Dux M, Messlinger K, (2002a). Increase in meningeal blood flow by nitric oxide-interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibition. Cephalalgia 22: 233-241.
85. Strecker T, Dux M, Messlinger K, (2002b). Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 39: 489-496.
86. Sun RQ, Tu YJ, Lawand NB, Yan JY, Lin Q, Willis WD, (2009). Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol 92: 2859-2866.
87. Vause CV, Durham PL, (2009). CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem 110: 811-821.
88. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL, (1997). Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17: 518-524.
89. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590.
90. Yong QC, Hu LF, Wang S, Huang D, Bian JS, (2010). Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res 88: 482-491.
91. Yong QC, Cheong JL, Hua F, Deng LW, Khoo YM, Lee HS, et al. (2011). Regulation of heart function by endogenous gaseous mediators-crosstalk between nitric oxide and hydrogen sulfide. Antioxid Redox Signal 14: 2081-2091.
92. Zagami AS, Goadsby PJ, Edvinsson L, (1990). Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16: 69-75.